Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
NCT00004296 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2005-06-24
Summary
OBJECTIVES: I. Determine the prevalence of nontuberculous mycobacteria in sputum cultures from patients with cystic fibrosis.
II. Compare the clinical course of patients with negative versus positive cultures.
Conditions
- Cystic Fibrosis
- Atypical Mycobacterium Infection
Sponsors & Collaborators
-
University of North Carolina
collaborator OTHER -
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Ken Olivier · University of North Carolina
Eligibility
- Min Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-09-30
More Related Trials
-
Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs
NCT00590330 ·Status: COMPLETED
-
A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida
NCT02198079 ·Status: COMPLETED
-
PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis
NCT02073409 ·Status: ENROLLING_BY_INVITATION
-
Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis
NCT02372383 ·Status: COMPLETED ·Phase: NA
-
Mucoid Staphylococcus Aureus in Cystic Fibrosis Airways
NCT04171583 ·Status: COMPLETED
-
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
NCT02419989 ·Status: ENROLLING_BY_INVITATION
-
Clinical Course and Changes in the Respiratory Microbiota Based on Antibiotic Treatment in Patients With Cystic Fibrosis
NCT01693965 ·Status: COMPLETED ·Phase: NA
-
Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation
NCT02480270 ·Status: COMPLETED
-
Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations
NCT04341532 ·Status: COMPLETED
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED
-
Microbiota of the Respiratory Flora in Children With Cystic Fibrosis During the First Year of Life
NCT00977158 ·Status: WITHDRAWN
-
Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
NCT00585364 ·Status: COMPLETED
-
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
NCT00043225 ·Status: COMPLETED
-
Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis Patients
NCT02550041 ·Status: TERMINATED ·Phase: NA
-
Inflammatory and Microbiologic Markers in Sputum: Comparing Cystic Fibrosis With Primary Ciliary Dyskinesia
NCT01155115 ·Status: COMPLETED ·Phase: NA
-
Characterization of Pulmonary Microbiome in Cystic Fibrosis Patients
NCT04735679 ·Status: UNKNOWN
-
Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis
NCT03684759 ·Status: COMPLETED
-
Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis
NCT00721071 ·Status: COMPLETED ·Phase: PHASE2
-
Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.
NCT02309229 ·Status: COMPLETED
-
Tissue Collection From People With Cystic Fibrosis
NCT00015756 ·Status: COMPLETED
-
Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients
NCT00669760 ·Status: COMPLETED
-
Near Patient Microbial Testing in Cystic Fibrosis
NCT01877707 ·Status: COMPLETED ·Phase: NA
-
Immune Profiles in CF Fungal Infection
NCT04476758 ·Status: COMPLETED
-
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
NCT01661491 ·Status: COMPLETED
-
Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
NCT06262282 ·Status: ENROLLING_BY_INVITATION